This project demonstrates the synthesis of amyloid-PET images from MRI scans, suggesting a novel diagnostic tool for Alzheimer's disease.
Motivation: Alzheimer's disease (AD) is marked by amyloid-beta plaques, typically detected through amyloid-PET imaging, which is expensive and limited in availability. Developing a more accessible diagnostic tool is essential for early detection and monitoring. Goal(s): This project aims to create a deep learning model that synthesizes amyloid-PET images from widely available MRI scans, offering a cost-effective, non-invasive alternative. Approach: A specialized VQGAN is trained to map MRI features to amyloid-PET images, utilizing datasets from patients across various stages of AD. Results: The model demonstrates accurate amyloid-PET synthesis, showing potential for early diagnosis and broad clinical application. Impact: This MRI-based deep learning method provides a cost-effective, non-invasive alternative to amyloid-PET imaging, potentially expanding diagnostic tools in clinical settings, especially where PET imaging is unavailable.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: